PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | C0011849|diabetes mellitus |
| Sentences | 137 |
| PubMedID- 20639213 | diabetes mellitus increases the risk of developing cardiovascular diseases such as coronary artery disease and heart failure. |
| PubMedID- 22952467 | Cardiovascular disease in patients with diabetes mellitus remains one of the leading causes of morbidity and mortality. |
| PubMedID- 26413719 | We also adjusted for body mass index and comorbidities including hypertension, diabetes mellitus and history of cerebrovascular disease (model 2, table 3). |
| PubMedID- 25532311 | The aim of the present study was to investigate the relationship of c-peptide levels with insulin, resistance; components of metabolic syndrome and cardiovascular disease in patients with diabetes mellitus type 2. |
| PubMedID- 23938049 | Dyslipidemia, undesirable changes in vascular endothelial and smooth muscle cells, lipid peroxidation especially oxidized low-density lipoprotein particles, oxidative damage and increased inflammatory mediators including chemokines and cytokines, hyper-coagulation and platelet activation have been considered as the main metabolic abnormalities in diabetes mellitus leading to cardiovascular disease . |
| PubMedID- 23466101 | Objectives: low levels of blood adiponectin contribute to an increased risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22615952 | Model 1: adjusted for age, bmi, current smoking, alcohol intake, exercise, diabetes mellitus, history of cardiovascular disease and history of malignancy. |
| PubMedID- 20415560 | Vitamin e reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. |
| PubMedID- 22291824 | We assessed the long-term effects of multifactorial intervention on lfts and their association with cardiovascular disease (cvd) events in patients with mets without diabetes mellitus or cvd. |
| PubMedID- 23238663 | Dietary interventions that could reduce the risk of development of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm) would clearly be advantageous instead of expensive pharmacological treatments. |
| PubMedID- 20040043 | to suggest that rosiglitazone may contribute to a decrease in the development of vascular diseases associated with type 2 diabetes mellitus through actions on pecam-1. |
| PubMedID- 24500563 | Despite the profound clinical importance of vascular disease in patients with diabetes mellitus, our understanding of the relative contributions of insulin resistance and hyperglycemia to atherogenesis is not complete. |
| PubMedID- 21963020 | Preliminary evidence in support of fruit intake for the prevention of cardiovascular disease in patients with type 2 diabetes mellitus (t2dm) is still limited. |
| PubMedID- 25708055 | This study aimed to assess the effects of active and passive smoking exposure on the development of cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24404539 | Clinically diagnosed diabetes mellitus with cardiovascular disease (dm+cvd) shall be the endpoint. |
| PubMedID- 20186491 | We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 21933841 | Purpose: to evaluate myocardial microvascular disease in patients with type 2 diabetes mellitus (dm) using myocardial contrast echocardiography (mce) and to report on its diagnostic accuracy using single photon emission tomography (spect) as reference test. |
| PubMedID- 20550659 | The action to control cardiovascular risk in diabetes (accord) study investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease 1. |
| PubMedID- 21359028 | although the metabolic syndrome unequivocally predisposes to type 2 diabetes mellitus, many investigators of cardiovascular diseases consider this syndrome a multidimensional risk factor for ascvd. |
| PubMedID- 24627825 | Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 24617860 | Context: dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus (dm). |
| PubMedID- 25326996 | Complications of diabetes mellitus include cardiovascular diseases, retinopathy, neuropathy and diabetic foot, which can in turn lead to lower extremity amputations. |
| PubMedID- 20877687 | Endothelial dysfunction is a major contributor to the pathogenesis of vascular disease in diabetes mellitus patients and has recently received increased attention. |
| PubMedID- 21854817 | Subjects with diabetes mellitus, evidence of myocardial infarction or cerebrovascular disease were excluded from the study. |
| PubMedID- 23185202 | Cardiovascular disease is common in patients with diabetes mellitus and related clinical outcomes are worse compared with non-diabetics. |
| PubMedID- 20350283 | Despite the profound clinical importance of vascular disease in patients with diabetes mellitus, our understanding of the molecular and cellular mechanisms by which diabetes promotes these vascular complications is incomplete. |
| PubMedID- 25815676 | Glucagon-like peptide-1 (glp-1) has been demonstrated to play an important role in type 2 diabetes mellitus, leading to cardiovascular diseases. |
| PubMedID- 26244041 | A recent review identified twelve risk equations for the prediction of cardiovascular disease in subjects with type 2 diabetes mellitus (t2dm) 6. |
| PubMedID- 19232762 | Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials. |
| PubMedID- 21625418 | The goal for non-hdl cholesterol has been reported to be the level of ldl cholesterol plus 30 mg/dl.36 in type 2 diabetics, several characteristics such as elevated triglycerides, decreased hdl cholesterol, and elevated small dense ldl, are well-known.25 because non-hdl cholesterol reflects all apolipoprotein b-containing atherogenic lipoproteins, non-hdl cholesterol may be useful in predicting cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 19925460 | We present a case of brutal diabetes mellitus in a patient with severe vascular disease that underwent a third pancreas transplant. |
| PubMedID- 25400702 | Aim: gestational diabetes mellitus (gdm) is associated with cardiovascular diseases; however, the relationship between epicardial fat thickness (eft) and gdm remains unclear. |
| PubMedID- 23798924 | positive results in different clinical trials have strengthen the value and acceptance of hscrp, which is recommended as a predictive laboratory marker for cardiovascular disease risk in patients with diabetes mellitus. |
| PubMedID- 24167560 | Hazard ratios were calculated after adjustment for age, sex, diabetes mellitus, previous history of cardiovascular disease, smoking status, systolic blood pressure, the use of lipid-lowering therapy, bmi, and biochemical data (hemoglobin, albumin, ca×p products, and log hs-crp levels). |
| PubMedID- 23144974 | In univariate analysis, age, diabetes mellitus, previous history of cardiovascular disease, smoking, lipid-lowering therapy, serum albumin, ipth, and hs-crp concentrations were significantly associated with the presence of aoac at baseline. |
| PubMedID- 22419928 | Cardiovascular disease in diabetes mellitus is multi-factorial and risk factors include hypertension, dyslipidaemia, insulin resistance and central obesity 8. |
| PubMedID- 24462067 | Results of epidemiologic studies that investigated the significance of pulse pressure (pp) and mean arterial pressure (map) in terms of risk of cardiovascular disease (cvd) in patients with diabetes mellitus are inconsistent. |
| PubMedID- 20977287 | However, although antiplatelet therapy with low-dose aspirin has been reported to prevent vascular events in high-risk patients with cardiovascular disease, recent studies in patients with pad or diabetes mellitus have failed to support the efficacy of aspirin in preventing vascular events in these patient populations. |
| PubMedID- 24678413 | The exclusion criteria were subjects who had diabetes mellitus, history of cardiovascular disease and heart failure, presence of cerebrovascular disease, arrhythmias (atrial fibrillation), history of ophthalmic surgery, cataract which affects the corrected visual acuity, glaucoma, and vitreous and retinal diseases. |
| PubMedID- 24567354 | Increased white blood cell (wbc) count is related to cardiovascular disease in patients with type 2 diabetes mellitus; raised neutrophil lymphocyte ratio (nlr) is associated with metabolic syndrome. |
| PubMedID- 26116592 | However, the clinical impact of apn and pai-1 in type 2 diabetes mellitus (t2dm) with macrovascular diseases (mvd) has not been investigated. |
| PubMedID- 21501602 | Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. |
| PubMedID- 21785619 | A therapeutic effect of myricetin in patients with cardiovascular diseases associated with diabetes mellitus has also been reported . |
| PubMedID- 24172142 | Furthermore, there was a strong increase in the proportion of patients between 40 and 70 years suffering from cardiovascular diseases in combination with hyperlipidemia and/or diabetes mellitus. |
| PubMedID- 25990316 | vascular disease in diabetes mellitus. |
| PubMedID- 23466074 | Role of relationship between hba1c, fibrinogen and hdl-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23393213 | Second, the presence of microvascular diseases commonly present in patients with diabetes mellitus may contribute to progressive microvascular ischemia or microembolization that can be readily detectable by highly sensitive ctni assay. |
| PubMedID- 25658588 | Abbreviations: bmi, body mass index; egfr, estimated glomerular filtration rate; proteinuria, proteinuria positive; dm, diabetes mellitus; cvd, history of cardiovascular disease; hyperuricemia, history of hyperuricemia including gout; alcohol, daily alcohol consumption; exercise, having regular exercise. |
| PubMedID- 21955281 | Background: type 2 diabetes mellitus increases the risk of atherosclerotic cardiovascular disease. |
| PubMedID- 20530022 | Management of diabetes mellitus in patients with cardiovascular disease in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial. |